CNS, psychiatry & neurology clinical trials built for early phase certainty
DVCR supports CNS, psychiatry and neurology studies with experienced scientific oversight, specialized assessment capabilities, integrated CRO services and technology-enabled data quality.
Start the conversation
Share a few details and our team will follow up to discuss your study, timelines and operational requirements.
Proven execution for complex CNS studies
CNS, psychiatry and neurology trials often depend on specialized procedures, subjective endpoint collection, trained raters and close coordination across clinical, operational and data teams. DVCR supports sponsors with experienced oversight, responsive study teams and integrated services designed to protect study quality from startup through reporting.
CNS-focused experience
DVCR’s investigators have participated in hundreds of psychiatric and neurologic clinical studies across all phases of research.
Scientific and medical oversight
CNS programs are supported by experienced leaders familiar with CNS drug classes, mechanisms of action, patient populations, procedures and assessments.
Specialized assessments
Study teams support CNS-specific procedures and scales including VAS, CSF sampling, PSG, EEG, CADSS, BPRS, MOAA/S, HAM-D, MADRS, ADAS-Cog, ADHD-RS, CGI, PHQ-9 and C-SSRS.
Early phase CRO support
DVCR supports FIH, SAD/MAD, NDA-enabling clinical pharmacology, HAP/HAL, Phase Ib/IIa proof-of-concept, Phase I-II multi-site patient trials and analog classroom studies for ADHD.
Integrated study execution
Project management, data management, biostatistics, statistical programming, PK/PD analysis and modeling, clinical and medical monitoring, medical writing as well as site feasibility, management and central laboratory services for Phase I-II multi-site trials with our global network of site partners.
Technology-enabled data quality
Integrated systems support real-time data capture, sponsor visibility, audit-ready documentation and cleaner study conduct.
Experience across psychiatric and neurologic indications
Key capabilities include:
DVCR supports CNS clinical trials across multiple psychiatric and neurologic indications, with strategic site partners for multi-site patient trials.
- Depression, including TRD and MDD
- Bipolar disorder
- Schizophrenia
- ADHD, including adult and pediatric populations
- Substance abuse disorders
- Epilepsy
- Alzheimer’s disease and dementia
- Parkinson’s disease
